GC Genome Corporation (KOSDAQ:340450)
South Korea · Delayed Price · Currency is KRW 5,190.00
+110.00 (2.17%)
Jun 11, 2026, 2:20 PM KST
GC Genome Market Cap
GC Genome has a market cap or net worth of 120.15 billion as of June 10, 2026.
Market Cap
120.15B
Enterprise Value
81.39B
Revenue
32.16B
Ranking
n/a
PE Ratio
25.56
Stock Price
5,190.00
Market Cap Chart
Since June 11, 2025, GC Genome's market cap has decreased from 262.52B to 120.15B, a decrease of -54.23%. That is a compound annual growth rate of -54.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 10, 2026 | 120.15B | -25.51% |
| Dec 30, 2025 | 161.30B | -38.56% |
| Jun 11, 2025 | 262.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.99T |
| Celltrion | 37.41T |
| ALTEOGEN | 17.49T |
| Samsung Epis Holdings | 10.48T |
| Ilsung Is | 134.08B |
| Macrogen | 131.07B |
| SAMSUNG PHARM. Co., LTD. | 126.78B |
| Shinhung | 126.31B |